Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Advanced Accelerator Applications
Marketing
5 pharmas lambasted by UK watchdog for marketing snafus
The U.K.’s drug marketing watchdog, the PMCPA, is having a busy summer. It flagged five companies for an array of breaches of its code.
Ben Adams
Aug 1, 2022 10:45am
Novartis snares tax abatement for $72M Lutathera plant
Dec 10, 2020 9:55am
Novartis plots 2nd U.S. plant to make cancer radiotherapies
Jul 1, 2020 9:45am
Novartis NET app gets an App Store launch boost
Jul 23, 2018 10:24am
Novartis wins FDA nod for newly acquired cancer drug Lutathera
Jan 26, 2018 3:10pm
With latest buy, Novartis snags drug with $2B sales potential
Oct 30, 2017 11:00am
